UnitedHealth Group Inc (UNH) Stock AnalysisUNHUnitedHealth Group Inc

UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

UnitedHealth Group Inc is a good buy right now due to its strong recent performance, including a 5-day price increase of 5.83% and a year-to-date change of 19.33%. The company also reported a Q3 adjusted EPS of $4.69, exceeding the analyst consensus of $4.14, and raised its 2026 EPS guidance to at least $20.50. However, there is a risk of insider selling, which has increased by 2854.33% over the last month, indicating potential concerns among insiders.

22 analysts cover UNH: 22 rate it Buy, 0 Hold and 0 Sell. The average price target is 397.82.